-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KW7NIi7jrOFIiLPGXu5gb5GbotEyqAJoqNHtCcE3Ix1Sz763kEaDzGk84Kt7peGS 3fVBOEU848RsJwo+UCPZgw== 0001181431-09-004628.txt : 20090123 0001181431-09-004628.hdr.sgml : 20090123 20090123172219 ACCESSION NUMBER: 0001181431-09-004628 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090122 FILED AS OF DATE: 20090123 DATE AS OF CHANGE: 20090123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUTTER MARTIN P CENTRAL INDEX KEY: 0001017832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 09543216 BUSINESS ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE SUITE 170 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 7133679999 MAIL ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE STREET 2: SUITE 170 CITY: THE WOODLAND STATE: TX ZIP: 77380 4 1 rrd230816.xml OPEN MARKET PURCHASE X0303 4 2009-01-22 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001017832 SUTTER MARTIN P 21 WATERWAY SUITE 225 THE WOODLANDS TX 77380 1 0 0 0 Common Stock 2009-01-22 4 P 0 27500 1.3349 A 40380 D Common Stock 2009-01-22 4 P 0 41409 1.3981 A 81789 D Common Stock 2009-01-23 4 P 0 5000 1.46 D 86789 D Common Stock 2009-01-23 4 P 0 26091 1.50 D 112880 D Common Stock 9748643 I By Essex Woodlands Health Ventures Fund VI, LP Common Stock 7807415 I By Essex Woodlands Health Ventures Fund VII, LP Common Stock 200 I Shares owned by Wife This number reflects the reverse split on a one-for-five basis of the common stock of La Jolla Pharmaceutical Company that occurred on December 21, 2005. The reporting person is a managing director of the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Martin P. Sutter 2009-01-23 -----END PRIVACY-ENHANCED MESSAGE-----